HeartSciences Inc. (HSCS) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.
The consensus price target is $3.00, representing an upside of 52.3% from the current price $1.97.
Analysts estimate Earnings Per Share (EPS) of $-20.00 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-18.74 vs est $-20.00 (beat +6.3%). 2025: actual $-9.34 vs est $-9.09 (missed -2.8%). Analyst accuracy: 95%.
HSCS Stock — 12-Month Price Forecast
$3.00
▲ +52.28% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for HeartSciences Inc., the price target is $3.00.
The average price target represents a +52.28% change from the last price of $1.97.
HSCS Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to HeartSciences Inc. in the past 3 months
EPS Estimates — HSCS
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$18.74
vs Est –$20.00
▲ 6.7% off
2025
Actual –$9.34
vs Est –$9.09
▼ 2.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — HSCS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 168.8% off
2025
Actual $0.000B
vs Est $0.000B
▼ 1,049.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
